Form D Explorer
Acurx Pharmaceuticals, Inc. · CIK 1736243

Citable research briefCompare issuerPrivate research collection

Acurx Pharmaceuticals, Inc.

CIK 1736243 · Corporation · Inc. DELAWARE · STATEN ISLAND, NY · Pharmaceuticals
Find website on Google
Sign up to follow
Filings
5
Original notices
5
Amendments
0
Activity
Jan 17, 2025
through Apr 29, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJun 27, 2025 · DApr 29, 2026 · DLater minus earlier
Reported offering amount$3,978,664$4,587,473$608,809
Reported amount sold$3,978,664$4,587,473$608,809
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001104659-25-063623 · Later SEC source: 0001736243-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Apr 29, 2026

Reported offering amount
$4,587,473
Reported amount sold
$4,587,473

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (5)